Federal Policy

U.S. reclassifies marijuana as less dangerous drug

By Intent.Health Team • April 23, 2026
U.S. Marijuana Reclassification Healthcare Market Signal

What's happening

The U.S. Department of Justice is moving to reclassify certain marijuana products as less dangerous, loosening federal restrictions.

This is considered one of the most significant federal drug policy shifts in decades.

What's changing / Business impact

  • Reduced regulatory barriers for: medical cannabis and FDA-approved cannabis products.
  • Increased investor confidence (stocks surged).
  • Potential expansion of: clinical research and therapeutic use.

Why this matters

Drug classification directly shapes: research, prescribing, and market access.

This shows:

  • Policy can unlock entire new treatment categories.
  • Regulatory shifts can move faster than clinical adoption.
  • Healthcare markets are influenced by legal frameworks, not just science.